Collectively, the results suggest that Zfp148 deficiency increases p53 activity in response to constitutively activated β-catenin during tumor initiation, and that newly transformed tumor cells are eliminated by p53-induced apoptosis in Zfp148-deficient mice. This evidence concerns the gene TP53 and neoplasm.